Similar response to biologic therapy across racial and ethnic groups among patients with psoriasis enrolled in the CorEvitas Psoriasis Registry

J Am Acad Dermatol. 2022 Nov;87(5):1087-1089. doi: 10.1016/j.jaad.2022.05.038. Epub 2022 May 26.
No abstract available

Keywords: QoL; biologic therapy; biologics; discontinuation; ethnicity; ethnoracial groups; outcomes; psoriasis; psoriatic disease; quality of life; race; switching; treatment response.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biological Products* / therapeutic use
  • Biological Therapy
  • Ethnicity
  • Humans
  • Psoriasis* / drug therapy
  • Registries

Substances

  • Biological Products